Medicago is a clinical-stage biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs). Medicago’s VLP manufacturing technology is based on a transient expression system which produces recombinant vaccine antigens in non-transgenic plants. This technology has the potential to offer speed and cost advantages over competitive technologies.


7 Triangle Drive
RTP, NC 27709

Additional Details

Arrived in RTP:
Global Headquarters:
Quebec City, Canada

Get In Touch

(919) 313-9670
Mailing Address:
PO Box 14545
RTP, NC 27709
General Contact:
Mike Wanner, CFO and US Site Manager
(919) 313-9670